Difference between revisions of "WSI23-111-Case-4"
From MGH Learn Pathology
(Created page with "{{ServiceRequestCase |requisition=null |subject=MGH |intent=order |basedOn=WSI23-111 |priority=routine |code=faculty |orderDetail=case |authoredOn=August 03, 2023 11:07:40 AM...") |
(Added status template) |
||
| (2 intermediate revisions by 2 users not shown) | |||
| Line 12: | Line 12: | ||
|sequence=4 | |sequence=4 | ||
|performer=RMN6 | |performer=RMN6 | ||
| − | |reasonCode=Case #4 - The patient is a 67-year-old male with past medical history significant for type II diabetes mellitus complicated by end-stage renal disease on maintenance peritoneal dialysis, presenting for initial evaluation of painful right leg lesions. Relevant laboratory results: Creatinine 10.74 mg/dL (reference interval 0.6-1.50 mg/dL), calcium 9.4 mg/dL (reference interval 8.5-10.5 mg/dL), phosphate 5.4 mg/dL (reference interval 2.6-4.5 mg/dL), PTH 230 pg/mL (reference interval 10-60 pg/mL). He has been treated in past for stasis dermatitis and cellulitis without resolution of his symptoms. On exam, there is a tender right shin lesion with brawny induration and no evident purpura; the lower medial calf shows dusky discoloration (see clinical photograph #4 | + | |reasonCode=Case #4 - The patient is a 67-year-old male with past medical history significant for type II diabetes mellitus complicated by end-stage renal disease on maintenance peritoneal dialysis, presenting for initial evaluation of painful right leg lesions. Relevant laboratory results: Creatinine 10.74 mg/dL (reference interval 0.6-1.50 mg/dL), calcium 9.4 mg/dL (reference interval 8.5-10.5 mg/dL), phosphate 5.4 mg/dL (reference interval 2.6-4.5 mg/dL), PTH 230 pg/mL (reference interval 10-60 pg/mL). He has been treated in past for stasis dermatitis and cellulitis without resolution of his symptoms. On exam, there is a tender right shin lesion with brawny induration and no evident purpura; the lower medial calf shows dusky discoloration (see clinical photograph #4). A punch biopsy is performed. |
|supportingInfo=4 | |supportingInfo=4 | ||
}} | }} | ||
| Line 21: | Line 21: | ||
|type=image | |type=image | ||
|subject=Z0FBQUFBQmt5NHFBQkN3UV9yeEkzdUhHYlFfWXlYYl8wSDN1WmhfWFBGM3hiYUVhZ0xteFF4MXNudm80WnBWOWpBa1VTYU9nVzJJX3ZsYzl1SUozeDR1VnF2Z0c5UXp4T1E9PQ | |subject=Z0FBQUFBQmt5NHFBQkN3UV9yeEkzdUhHYlFfWXlYYl8wSDN1WmhfWFBGM3hiYUVhZ0xteFF4MXNudm80WnBWOWpBa1VTYU9nVzJJX3ZsYzl1SUozeDR1VnF2Z0c5UXp4T1E9PQ | ||
| + | |reasonCode=H&E | ||
|view=show | |view=show | ||
|modality=mrxs | |modality=mrxs | ||
| + | |identifier=f9c9033b-b314-4229-b592-ceb86fcab6e5 | ||
| + | }} | ||
| + | {{Media | ||
| + | |createdDateTime=August 03, 2023 11:34:14 AM | ||
| + | |operator=Em99 | ||
| + | |status=completed | ||
| + | |type=image | ||
| + | |subject=Z0FBQUFBQmt5NUM4cDhHZGRNT0pmOUFRNzlfak92aFBsaU9yUUZ0YjZrYVV5bV8tUDhDbEFOYlU3Ny1QcHdfVHdTV3dLWGNISWEzVGZmVXlWemdPNGVYRGlVSXlvSWowcFE9PQ | ||
| + | |reasonCode=Von Kossa | ||
| + | |view=show | ||
| + | |modality=mrxs | ||
| + | |identifier=45f299e9-f4ed-4aad-b2ef-57093cb427ba | ||
| + | }} | ||
| + | {{status | ||
| + | |status=active | ||
| + | |requester=Em99 | ||
| + | |authoredOn=August 03, 2023 11:07:40 AM | ||
}} | }} | ||
Latest revision as of 15:43, December 9, 2024
